218 related articles for article (PubMed ID: 4145343)
41. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Johnson AM; Loew DM; Vigouret JM
Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
[TBL] [Abstract][Full Text] [Related]
42. Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
Kulkarni SK; Dandiya PC
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):45-50. PubMed ID: 1233511
[TBL] [Abstract][Full Text] [Related]
43. In vivo inhibition of striatal acetycholine turnover by L-DOPA, apomophine and (plus)-amphetamine.
Trabucchi M; Cheney DL; Racagni G; Costa E
Brain Res; 1975 Feb; 85(1):130-4. PubMed ID: 1109691
[No Abstract] [Full Text] [Related]
44. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
Bläsig J; Papeschi R; Herz A
Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
[No Abstract] [Full Text] [Related]
45. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
[TBL] [Abstract][Full Text] [Related]
46. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
Miller R; Horn A; Iversen L; Pinder R
Nature; 1974 Jul; 250(463):238-41. PubMed ID: 4368645
[No Abstract] [Full Text] [Related]
47. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
[TBL] [Abstract][Full Text] [Related]
48. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.
Kelly PH; Seviour PW; Iversen SD
Brain Res; 1975 Sep; 94(3):507-22. PubMed ID: 1171714
[TBL] [Abstract][Full Text] [Related]
49. Striatal A2 receptor regulates apomorphine-induced turning in rats with unilateral dopamine denervation.
Brown SJ; Gill R; Evenden JL; Iversen SD; Richardson PJ
Psychopharmacology (Berl); 1991; 103(1):78-82. PubMed ID: 1900945
[TBL] [Abstract][Full Text] [Related]
50. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
Symchowicz S; Korduba CA; Veals J
Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
[No Abstract] [Full Text] [Related]
51. Effect of long-term L-dopa administration on brain biogenic amines and behavior in the rat.
Narotzky R; Griffith D; Stahl S; Bondareff W; Zeller EA
Exp Neurol; 1973 Feb; 38(2):218-30. PubMed ID: 4690179
[No Abstract] [Full Text] [Related]
52. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).
Hornykiewicz O
Br Med Bull; 1973 May; 29(2):172-8. PubMed ID: 4356552
[No Abstract] [Full Text] [Related]
53. The effect of amantadine, L-dopa, (plus)-amphetamine and apomorphine on the acquisition of the conditioned avoidance response.
Davies JA; Jackson B; Redfern PH
Neuropharmacology; 1974 Mar; 13(3):199-204. PubMed ID: 4840843
[No Abstract] [Full Text] [Related]
54. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
Mason ST; Iverson SD
Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
[No Abstract] [Full Text] [Related]
55. Modification by L-DOPA methylester (H 19-61) of amphetamine-induced brain catecholamine changes, thermal responses and toxicity in developing mice.
Alhava E
Acta Pharmacol Toxicol (Copenh); 1973; 33(5):330-47. PubMed ID: 4801079
[No Abstract] [Full Text] [Related]
56. Correlation of functional recovery after a 6-hydroxydopamine lesion with survival of grafted fetal neurons and release of dopamine in the striatum of the rat.
Rioux L; Gaudin DP; Bui LK; Grégoire L; DiPaolo T; Bédard PJ
Neuroscience; 1991; 40(1):123-31. PubMed ID: 1904997
[TBL] [Abstract][Full Text] [Related]
57. Effects of chronic morphine treatment on dopamine-mediated turning behaviour in rats and mice with 6-hydroxydopamine-induced unilateral nigro-striatal lesions.
Slater P; Crossman AR
Neuropharmacology; 1980 Mar; 19(3):289-95. PubMed ID: 7191487
[No Abstract] [Full Text] [Related]
58. Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine.
Yehuda S; Wurtman RJ
Nature; 1972 Dec; 240(5382):477-8. PubMed ID: 4565945
[No Abstract] [Full Text] [Related]
59. Acute effects of 6-hydroxydopa on central monoaminergic neurons.
Kostrzewa R; Jacobwitz D
Eur J Pharmacol; 1973 Jan; 21(1):70-80. PubMed ID: 4709209
[No Abstract] [Full Text] [Related]
60. Self-stimulation reward pathways: norepinephrine vs dopamine.
Stein L; Belluzzi JD; Ritter S; Wise CD
J Psychiatr Res; 1974; 11():115-24. PubMed ID: 4461783
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
